ELIZABETH HARTLAUB: Open Payments
NPI 1518310598 · WESLEY CHAPEL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 40 payments from 13 companies in 2025. Trend: 2023 $1,125 · 2024 $1,445 · 2025 $840
Food & beverage: $840
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $220 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $112 |
| Neurocrine BioSciences, Inc. | 4 | $97 |
| Vanda Pharmaceuticals Inc. | 2 | $67 |
| Corium, LLC | 3 | $61 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| Supernus Pharmaceuticals, Inc. | 3 | $48 |
| Alkermes, Inc. | 2 | $47 |
| Almatica Pharma LLC | 2 | $38 |
| Lundbeck LLC | 1 | $25 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, Azstarys, AUSTEDO XR, Qelbree, LYBALVI, REXULTI.
Industry payments across FL — which companies pay providers there.
